Latest Headlines Nova Measuring Instrum
Post# of 63849
Posted On: 02/24/2014 7:57:39 AM
- Nova Measuring Instruments to Present at Upcoming Investor Conferences
- SAIC Sector President Nazzic Keene Joins Wolf Trap Board of Directors
- Holder urges congressional action on data breaches
- Oiltanking Partners Announces Fourth Quarter 2013 Earnings Release and Conference Call Schedule
- WhatsApp to add voice to messaging service
- Ukraine issues arrest warrant for missing leader
- Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion
- Ilan Kaplan Appointed CEO of Magal Subsidiary, CyberSeal
- Actions Semiconductor's Tablet Chipsets Provide Advanced, Efficient Graphics with Imagination's PowerVR GPUs
- Verizon Projects Higher Margins and Sustained Revenue Growth in 2014
- Qualcomm Integrates Bluetooth® Low Energy in its Award-Winning 2net Hub to Enable Connected Medical and Fitness Devices
- AcelRx Pharmaceuticals to Hold Fourth Quarter and Annual 2013 Financial Results Conference Call and Webcast on Monday, March 3, 2014
- Palatin Technologies Presents Positive New Data Analyses Demonstrating Efficacy of Bremelanotide in Female Hypoactive Sexual Desire Disorder
- W. P. Carey Updates Timing of Release of Fourth Quarter and Year-End 2013 Financial Results to Monday, March 3, 2014
- Benitec Biopharma Announces Private Placement of Ordinary Shares and Warrants
- Markets drift amid Chinese property fears
- Alacer announces results of exploration in Turkey
- Ball Aerospace Delivers Phased Array Antennas for Orion Inaugural Flight
- Eurozone inflation stable at low level in January
- RXi Pharmaceuticals to Present at the 24th Annual Wall Street Analyst Forum
- RADCOM to Present at the Roth Conference in California, March 9rd-12th, 2014
- biOasis Technologies Begins Trading on OTCQX®
- Palo Alto Networks Reports Fiscal Second Quarter 2014 Financial Results
- BioLineRx Appoints Dr. Sandra Panem to Board of Directors
- PDL BioPharma to Announce Fourth Quarter and Full Year 2013 Financial Results on March 3, 2014
More Stories
(0)
(0)